EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-ND 4.0

Efficacy and Safety of Letrozole, Misoprostol and Their Combination in First Trimester Missed Miscarriage: A randomised clinical trial

Mohamed Fikry Yousef, Mamdouh Abdelfatah Sheeba, Hany Saad Amin Mohamed, Abdelrahman Adel Abdelmonem Salama, Ahmed Hassan, Marwan Taghian, Mahmoud Mostafa Hassan Ali, Ahmed Ragab Ebrahim Ragab, Ahmed Hassan, Amira Alasmer, Mohamed Ramadan Mohamed

Sultan Qaboos University Medical Journal · 29.01.2026 · 26 (1) · 84-91

DOI: 10.18295/2075-0528.2962 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sultan Qaboos University Medical Journal, online erschienen am 29.01.2026. Verfasst von Mohamed Fikry Yousef und 10 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Misoprostol, Letrozole, Abortion, Missed. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study evaluated the efficacy and safety of misoprostol, letrozole and their combination in first trimester missed miscarriage.

Methods

This single-blind, randomised controlled trial was conducted between March 2023 and August 2024 among women diagnosed with first trimester missed miscarriage at Kasr Al-Aini Hospital, Cairo, Egypt. Participants were randomly assigned to three groups: misoprostol-only (Group A), letrozole plus misoprostol (Group B) and letrozole-only (Group C). The primary outcome was the rate of complete miscarriage. Secondary outcomes included abortion timing, adverse effects, need for surgical evacuation and the effect of age, body mass index (BMI) and gestational age on success.

Results

A total of 225 women were included in this study. Group B had the highest cumulative complete miscarriage rate by day 7 (76.0%) compared with Group A (53.5%) and Group C (62.5%) (P = 0.0005). Early abortion (by day 4) occurred in 68.4% (group B), 46.5% (group A) and 37.5% (group C). Group B also had the highest incidence of adverse effects, particularly bleeding (85.3%) and pain (92.0%), although severe events were rare. Letrozole-only (group C) had the fewest side effects (26.7%) and required no surgical evacuations. Combination therapy proved most effective across subgroups by age, BMI and gestational age.

Conclusion

Combining letrozole with misoprostol significantly improves complete miscarriage rates with tolerable safety. Letrozole alone is safer but less effective. Thus, combination therapy may offer an optimal non-surgical strategy for individualised management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolLetrozoleAbortion, MissedHumansFemalePregnancyAdultPregnancy Trimester, FirstSingle-Blind MethodEgyptAbortifacient Agents, NonsteroidalDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

AbortionLetrozoleMisoprostolOman

Substanzen

MisoprostolLetrozoleAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Obstetrics and Gynecology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Diagnostic and Interventional Radiology Department, Cairo University, Cairo, Egypt.
  • Columbia University Irving Medical Center, New York, USA.
  • Oncosurgery Department, NHS Lothian, Lothian, United Kingdom.
  • Oncosurgery Department, 6th October Hospital for Health Insurance, Cairo, Egypt.
  • Alharam Specialized Hospital, Cairo, Egypt.

Zitieren

APA

Fikry Yousef, M., Abdelfatah Sheeba, M., Saad Amin Mohamed, H., Adel Abdelmonem Salama, A., Hassan, A., Taghian, M., Mostafa Hassan Ali, M., Ragab Ebrahim Ragab, A., Hassan, A., Alasmer, A., & Ramadan Mohamed, M. (2026). Efficacy and Safety of Letrozole, Misoprostol and Their Combination in First Trimester Missed Miscarriage: A randomised clinical trial. Sultan Qaboos University Medical Journal, 26(1), 84-91. https://doi.org/10.18295/2075-0528.2962

Vancouver

Fikry Yousef M, Abdelfatah Sheeba M, Saad Amin Mohamed H, Adel Abdelmonem Salama A, Hassan A, Taghian M, et al. Efficacy and Safety of Letrozole, Misoprostol and Their Combination in First Trimester Missed Miscarriage: A randomised clinical trial. Sultan Qaboos University Medical Journal. 2026;26(1):84-91. doi:10.18295/2075-0528.2962

BibTeX
@article{FikryYousef2026,
  author = {Fikry Yousef, Mohamed and Abdelfatah Sheeba, Mamdouh and Saad Amin Mohamed, Hany and Adel Abdelmonem Salama, Abdelrahman and Hassan, Ahmed and Taghian, Marwan and Mostafa Hassan Ali, Mahmoud and Ragab Ebrahim Ragab, Ahmed and Hassan, Ahmed and Alasmer, Amira and Ramadan Mohamed, Mohamed},
  title = {Efficacy and Safety of Letrozole, Misoprostol and Their Combination in First Trimester Missed Miscarriage: A randomised clinical trial},
  journal = {Sultan Qaboos University Medical Journal},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {84--91},
  doi = {10.18295/2075-0528.2962}
}
Kostenlos starten →